MELISSA ROSE: Open Payments
NPI 1093111924 · RANDLEMAN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 46 payments from 16 companies in 2025. Trend: 2023 $892 · 2024 $740 · 2025 $1,193
Food & beverage: $1,014Education: $179
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $367 |
| JAZZ PHARMACEUTICALS INC. | 7 | $265 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Grifols USA, LLC | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Insmed, Inc. | 2 | $54 |
| Verona Pharma, Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $30 |
Products named: NUCALA, XYWAV, Prolastin-C Liquid, DUPIXENT, Arikayce, Ohtuvayre, OFEV, JASCAYD.
Industry payments across NC — which companies pay providers there.
